496 related articles for article (PubMed ID: 19531065)
1. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
2. Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor.
Baldys A; Göoz M; Morinelli TA; Lee MH; Raymond JR; Luttrell LM; Raymond JR
Biochemistry; 2009 Feb; 48(7):1462-73. PubMed ID: 19173594
[TBL] [Abstract][Full Text] [Related]
3. Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.
Odintsova E; van Niel G; Conjeaud H; Raposo G; Iwamoto R; Mekada E; Berditchevski F
J Biol Chem; 2013 Sep; 288(36):26323-26334. PubMed ID: 23897813
[TBL] [Abstract][Full Text] [Related]
4. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.
Stern KA; Place TL; Lill NL
Biochem J; 2008 Mar; 410(3):585-94. PubMed ID: 18045238
[TBL] [Abstract][Full Text] [Related]
5. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
6. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.
Henriksen L; Grandal MV; Knudsen SL; van Deurs B; Grøvdal LM
PLoS One; 2013; 8(3):e58148. PubMed ID: 23472148
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
8. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.
Alwan HA; van Zoelen EJ; van Leeuwen JE
J Biol Chem; 2003 Sep; 278(37):35781-90. PubMed ID: 12829707
[TBL] [Abstract][Full Text] [Related]
9. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
[TBL] [Abstract][Full Text] [Related]
10. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
11. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H; Komurasaki T; Toyoda H; Dean C
Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
[TBL] [Abstract][Full Text] [Related]
12. EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling.
Wilson KJ; Mill C; Lambert S; Buchman J; Wilson TR; Hernandez-Gordillo V; Gallo RM; Ades LM; Settleman J; Riese DJ
Growth Factors; 2012 Apr; 30(2):107-16. PubMed ID: 22260327
[TBL] [Abstract][Full Text] [Related]
13. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
14. Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation.
Faria JAQA; de Andrade C; Goes AM; Rodrigues MA; Gomes DA
Biochem Biophys Res Commun; 2016 Sep; 478(1):39-45. PubMed ID: 27462018
[TBL] [Abstract][Full Text] [Related]
15. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin exosomes increase cancer cell invasion.
Higginbotham JN; Demory Beckler M; Gephart JD; Franklin JL; Bogatcheva G; Kremers GJ; Piston DW; Ayers GD; McConnell RE; Tyska MJ; Coffey RJ
Curr Biol; 2011 May; 21(9):779-86. PubMed ID: 21514161
[TBL] [Abstract][Full Text] [Related]
17. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
Wang LM; Kuo A; Alimandi M; Veri MC; Lee CC; Kapoor V; Ellmore N; Chen XH; Pierce JH
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6809-14. PubMed ID: 9618494
[TBL] [Abstract][Full Text] [Related]
18. Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.
Rittié L; Kansra S; Stoll SW; Li Y; Gudjonsson JE; Shao Y; Michael LE; Fisher GJ; Johnson TM; Elder JT
Am J Pathol; 2007 Jun; 170(6):2089-99. PubMed ID: 17525275
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.
Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH
J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
